Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Narrden, Netherlands
SEC filing record 1 source field available
Fiscal year end
31 December
NewAmsterdam Pharma Co N.V. has filed 412 SEC EDGAR filings since 04 Aug 2022

SEC filing history

Showing 176-200 of 412 matching filings.

Per page
25
Current page
8
4

4

Filing date
07 Jan 2025
Reporting date
07 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Jan 2025
Reporting date
07 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
06 Jan 2025
Reporting date
02 Jan 2025
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
02 Jan 2025
Reporting date
30 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
30 Dec 2024
Reporting date
26 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
26 Dec 2024
Reporting date
20 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
20 Dec 2024
Reporting date
18 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
18 Dec 2024
Reporting date
16 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-93833

SC 13D/A

Filing date
17 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
17 Dec 2024
Reporting date
13 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-93833

SC 13D/A

Filing date
17 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-93833

SC 13D/A

Filing date
17 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
16 Dec 2024
Reporting date
12 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-280687

424B5

Filing date
13 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
12 Dec 2024
Reporting date
10 Dec 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3MEF File 333-283740

S-3MEF

Filing date
11 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-280687

424B5

Filing date
10 Dec 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .